OceanBase Hosts Technical Symposium on Data x AI and Has Six Papers Accepted at ICDE 2025

OceanBase Hosts Technical Symposium on Data x AI and Has Six Papers Accepted at ICDE 2025

HONG KONG, May 23, 2025 /PRNewswire/ -- OceanBase hosted a technical symposium during the annual IEEE International Conference on Data Engineering (ICDE 2025), a leading global conference in data and information engineering held in Hong Kong this...

Fourth NDA for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation

Fourth NDA for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation

CHENGDU, China, May 22, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new indication application (the "Application") for the Company's trophoblast cell-surface antigen 2 (TROP2)-directed...

Qifu Technology's Paper Accepted by IJCAI 2025, Using MLLM to Pave New Path in Fintech

Qifu Technology's Paper Accepted by IJCAI 2025, Using MLLM to Pave New Path in Fintech

SHANGHAI, May 7, 2025 /PRNewswire/ -- China's leading fintech company Qifu Technology ( NASDAQ: QFIN; HKEX: 3660) and Beijing Jiaotong University have jointly achieved a significant milestone as their paper, Leveraging MLLM Embeddings and Attribute...

TPIsoftware's digiRunner Wins Vietnam Sao Khue Awards 2025 for Retail Ecosystem Innovation

TPIsoftware's digiRunner Wins Vietnam Sao Khue Awards 2025 for Retail Ecosystem Innovation

TAIPEI, April 29, 2025 /PRNewswire/ -- TPIsoftware (TWSE: 7781), Taiwan's leading software company specializing in digital transformation, has been awarded the Sao Khue Awards 2025 in recognition of its API management platform digiRunner's proven...

Caliway's CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal

Caliway's CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal

Advancing Scientific Recognition in Non-Surgical Fat Reduction Caliway's CBL-514 Phase 2 study (CBL-0202) has been accepted for publication in Aesthetic Surgery Journal (ASJ), the top-ranked journal in aesthetic medicine and plastic surgery....

Winners Announced in 19th Annual Stevie® Awards for Sales & Customer Service

Winners Announced in 19th Annual Stevie® Awards for Sales & Customer Service

World's Top Customer Service and Sales Awards Winners to be Honored at Ceremony in New York City FAIRFAX, Va., March 6, 2025 /PRNewswire/ -- Winners in the 19th annual Stevie® Awards for Sales & Customer Service, recognized as the world's top...

WUSD Now Accepted at Iconic Metro Department Store Through dtcpay Integration

WUSD Now Accepted at Iconic Metro Department Store Through dtcpay Integration

SINGAPORE, Feb. 28, 2025 /PRNewswire/ -- Worldwide Stablecoin Payment Network (WSPN) is pleased to announce that its flagship stablecoin, WUSD, is now accepted at Metro Department Store through dtcpay's innovative payment solution. This development...

IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health

IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health

SHANGHAI and NANJING, China and SAN JOSE, Calif., Feb. 14, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies...

Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA

Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA

HONG KONG, Jan. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been accepted...

Shining at CES 2025, TCL Garners Multiple Awards for Display Innovations and Smart Home Solutions

Shining at CES 2025, TCL Garners Multiple Awards for Display Innovations and Smart Home Solutions

LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- TCL Electronics, a leading consumer electronics brand and the world's top two TV brand, has been honored with multiple awards at CES 2025, demonstrating its technological excellence in display innovations and...

  • 1
  • 2
  • menu
    menu